OncoTag
Business Services · Brazil · 1-10 Employees
View Company Info for Free
Overview
Headquarters
115 Av. Princesa Diana, Nova Lima, Minas...Phone Number
+55 31975595730Website
www.oncotag.com.brRevenue
<$5 MillionIndustry
ZI Rank: 1
About OncoTag
OncoTag Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OncoTag your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if OncoTag is spiking on competitors!
Earning: See what the market has to say on OncoTag recently announced quarterly report
Product Launch: Get notified when OncoTag launches new products
Congratulate Masked Content for being promoted to Masked Content at OncoTag
Funding: Get notified immidiatlly once OncoTag has new funding data
Website visits: Recent activity has been detected on your website
OncoTag, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if OncoTag has recently received funding, and reach out quickly before it becomes old news!
Click to see if OncoTag had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined OncoTag as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
OncoTag is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
OncoTag is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OncoTag.
OncoTag Tech Stack
A closer look at the technologies used by OncoTag
Top Business Services Companies
Frequently Asked Questions Regarding OncoTag
Oncotag specializes in translational research and pharmacogenetics, focusing on the connections between basic research and clinical application to personalize cancer treatments based on individual genetics. They offer the ElasTag panel, a genetic test for women with triple-negative breast cancer and ovarian cancer, utilizing artificial intelligence... Read More
